Exec: Device tax counters principles of economic growth, job creation

11/21/2011 | Plain Dealer (Cleveland), The

The 2.3% medical device excise tax could lead to job cuts in the medtech industry by lowering the demand for costly devices and driving U.S. firms to move their operations overseas, writes BioOhio President and CEO Tony Dennis, citing an AdvaMed study. The tax, set to begin in 2013, "is counter to principles of economic growth and job creation" and "may stifle the kind of innovation that is essential to patients and the overall health care system," Dennis notes.

View Full Article in:

Plain Dealer (Cleveland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC